{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:27:42Z","timestamp":1787120862706,"version":"build-2736575974"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metastasis is the primary cause of treatment failure and adverse prognosis in hepatocellular carcinoma (HCC), and the molecular basis of HCC metastasis remains poorly defined. This work investigated the potential mechanisms underlying HCC metastasis through integrated multi-omics analysis of metabolomics and proteomics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This retrospective study included 105 individuals with HCC, with comparative analysis between metastatic and non-metastatic cases. We further evaluated the effects of metastasis on serum metabolomics and proteomics in HCC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      Widespread disturbances in amino acid metabolism were identified via untargeted metabolomics in HCC patients with metastasis, closely governing inflammation-related metabolic remodeling and oxidative stress responses. Specifically, we identified 91 and 59 distinct differential metabolites capable of indicating HCC metastasis, with the screening criteria set as log\n                      <jats:sub>2<\/jats:sub>\n                      fold change &amp;gt; 1.5, adjusted\n                      <jats:italic>P<\/jats:italic>\n                      value &amp;lt; 0.05, and VIP &amp;gt; 1.5 in positive and negative modes, respectively. The alanine, aspartate and glutamate metabolism pathway correlated with HCC-associated lung metastasis, while the gluconeogenesis pathway was linked to HCC-associated bone metastasis. Compared with HCC (non-metastatic hepatocellular carcinoma), the key molecular alterations in the multi-omics network of HCC_M (HCC with metastasis) are implicated in inflammatory metabolic reprogramming, oxidative stress response, gluconeogenesis, glycolysis, and the tricarboxylic acid (TCA) cycle. Twenty-five proteins, including PKM2, PERCK, ALDH2, CPS1, GLS1, GLUD1, GOT1, and SLC38A2, were identified as potential biomarkers for HCC metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By integrating untargeted metabolomic and proteomic profiling, we identified distinct metabolic and proteomic changes linked to HCC metastasis. This work also characterized the pathological characteristics and core pathways underlying HCC metastasis, while identifying potential therapeutic candidates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1856643","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:46:55Z","timestamp":1787118415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated multi-omics analysis of metabolomics and proteomics uncovers dysregulated amino acid metabolism in HCC metastasis"],"prefix":"10.3389","volume":"17","author":[{"given":"Jing","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Central Hospital, Tianjin University\/Tianjin Third Central Hospital, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Central Hospital, Tianjin University\/Tianjin Third Central Hospital, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Central Hospital, Tianjin University\/Tianjin Third Central Hospital, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0758","article-title":"Systemic therapy of advanced hepatocellular carcinoma","volume":"17","author":"Galle","year":"2020","journal-title":"Future Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06260-z","article-title":"Identification of METTL3 as an adverse prognostic biomarker in hepatocellular carcinoma","volume":"66","author":"Liu","year":"2020","journal-title":"Digestive Dis Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70045","article-title":"PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification","volume":"14","author":"Wang","year":"2024","journal-title":"Clin Transl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-24-1409","article-title":"PLT012, a humanized CD36-blocking antibody, is effective for unleashing antitumor immunity against liver cancer and liver metastasis","volume":"15","author":"Tzeng","year":"2025","journal-title":"Cancer Discov"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/mas.21896","article-title":"Metabolomics for dental caries diagnosis: past, present, and future","volume":"44","author":"Ahmad","year":"2024","journal-title":"Mass Spectrom Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ccell.2024.07.005","article-title":"Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers","volume":"42","author":"Sun","year":"2024","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2025.102546","article-title":"Integrating transcriptome and metabolomics analyses of hepatocellular carcinoma to discover novel biomarkers and drug targets","volume":"49","author":"Yang","year":"2025","journal-title":"Clinics Res Hepatol Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100143","article-title":"Integrated LC-MS metabolomics with dual derivatization for quantification of FFAs in fecal samples of hepatocellular carcinoma patients","volume":"62","author":"Zhang","year":"2021","journal-title":"J Lipid Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325189","article-title":"Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156892","article-title":"Predicting the molecular mechanism of ginger targeting PRMT1\/BTG2 axis to inhibit gastric cancer based on WGCNA and machine algorithms","volume":"143","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S504717","article-title":"Identification and validation of pivotal genes in osteoarthritis combined with WGCNA analysis","volume":"18","author":"Yang","year":"2025","journal-title":"J Inflammation Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2013.01.015","article-title":"UPLC-ESI-QTOF\/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant","volume":"768","author":"Barri","year":"2013","journal-title":"Anal Chim Acta"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012780","article-title":"Proteomic characterization and comparison of the infective and adult life stage secretomes from Necator americanus and Ancylostoma ceylanicum","volume":"19","author":"Traub-Csek\u00f6","year":"2025","journal-title":"PloS NeglTrop Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12883-025-04091-x","article-title":"Mendelian randomization of plasma proteomics identifies novel ALS-associated proteins and their GO enrichment and KEGG pathway analyses","volume":"25","author":"Lu","year":"2025","journal-title":"BMC Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2025.105843","article-title":"WGCNA-based integration of transcriptomics and metabolomics reveals key meat quality regulators during development in Jingyuan chickens","volume":"104","author":"Zhao","year":"2025","journal-title":"Poult Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/all.16434","article-title":"Multiomic integration analysis for monitoring severe asthma treated with mepolizumab or omalizumab","volume":"80","author":"Contreras","year":"2024","journal-title":"Allergy"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1967-4_15","article-title":"Multivariate analysis with the R package mixOmics","volume":"2426","author":"Welham","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1242\/bio.017863","article-title":"Metabolomics reveals significant variations in metabolites and correlations regarding the maturation of walnuts (Juglans regia L.)","volume":"5","author":"Rao","year":"2016","journal-title":"Biol Open"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001304","article-title":"CAD manipulates tumor intrinsic DHO\/UBE4B\/NF-\u03baB pathway and fuels macrophage cross-talk, promoting HCC metastasis","volume":"83","author":"Pan","year":"2026","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47040263","article-title":"Decoding hepatocellular carcinoma metastasis: molecular mechanisms, targeted therapies, and potential biomarkers","volume":"47","author":"Wei","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2174\/0115680266366687250730060318","article-title":"Research progress on the mechanisms of traditional Chinese medicine in preventing and treating HCC invasion and metastasis based on lipid metabolic reprogramming","volume":"25","author":"Wang","year":"2025","journal-title":"Curr Top Med Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1123192","article-title":"Amino acid metabolic reprogramming in tumor metastatic colonization","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17111751","article-title":"Unveiling the maze: branched-chain amino acids fueling the dynamics of cancer metabolism and progression","volume":"17","author":"Xu","year":"2025","journal-title":"Cancers"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.819835","article-title":"The amino acids sensing and utilization in response to dietary aromatic amino acid supplementation in LPS-induced inflammation piglet model","volume":"8","author":"Duanmu","year":"2022","journal-title":"Front Nutr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1717414","article-title":"Targeting emerging amino acid dependencies and transporters in cancer therapy","volume":"16","author":"Akinlalu","year":"2025","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-3561","article-title":"PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12920-022-01380-z","article-title":"An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma","volume":"15","author":"Bai","year":"2022","journal-title":"BMC Med Genomics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402703","article-title":"Loss of carbamoyl phosphate synthetase 1 potentiates hepatocellular carcinoma metastasis by reducing aspartate level","volume":"11","author":"Chen","year":"2024","journal-title":"Adv Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/2025.07.29.667471","article-title":"Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer","volume":"12","author":"Montoya","year":"2025","journal-title":"Biol Arch"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17998\/jlc.2025.03.07","article-title":"Antitumor role of L-arginine and argininosuccinate synthetase 1 in hepatocellular carcinoma: direct and immunological mechanisms","volume":"25","author":"Eun","year":"2025","journal-title":"J Liver Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215880","article-title":"Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity","volume":"547","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1592837","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf412","article-title":"DriverOmicsNet: an integrated graph convolutional network for multi-omics exploration of cancer driver genes","volume":"26","author":"Dai","year":"2025","journal-title":"Briefings Bioinf"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102458","article-title":"GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism","volume":"56","author":"Zhou","year":"2022","journal-title":"Redox Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103103","article-title":"Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment","volume":"71","author":"Qian","year":"2024","journal-title":"Redox Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.02.008","article-title":"The role of ALDH2 in tumorigenesis and tumor progression: targeting ALDH2 as a potential cancer treatment","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-021-03782-w","article-title":"TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation","volume":"12","author":"Gao","year":"2021","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7150\/jca.64195","article-title":"Glutamate dehydrogenase 1 mediated glutaminolysis sustains HCC cells survival under glucose deprivation","volume":"13","author":"Zhou","year":"2022","journal-title":"J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-071516-044546","article-title":"Glutaminolysis: a hallmark of cancer metabolism","volume":"19","author":"Yang","year":"2017","journal-title":"Annu Rev BioMed Eng"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.114791","article-title":"Lung cancer cell-intrinsic asparagine synthetase potentiates anti-tumor immunity via modulating immunogenicity and facilitating immune remodeling in metastatic tumor-draining lymph nodes","volume":"21","author":"Zhang","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115529","article-title":"Amino acids in cancer: understanding metabolic plasticity and divergence for better therapeutic approaches","volume":"44","author":"Do","year":"2025","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216653","article-title":"Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3\u03b2\/\u03b2-catenin\/EMT pathway","volume":"586","author":"Tan","year":"2024","journal-title":"Cancer Lett"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00800-3","article-title":"Moonlighting functions of glucose metabolic enzymes and metabolites in cancer","volume":"25","author":"Guo","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbcan.2019.05.006","article-title":"Gluconeogenesis in cancer cells - repurposing of a starvation-induced metabolic pathway","volume":"1872","author":"Grasmann","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1142838","article-title":"The immunomodulatory role of IDO1-Kynurenine-NAD+ pathway in switching cold tumor microenvironment in PDAC","volume":"13","author":"Anu","year":"2023","journal-title":"Front Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.10.026","article-title":"An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC","volume":"84","author":"Zhang","year":"2026","journal-title":"J Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03550-6","article-title":"RBM30 recruits DOT1L to activate STAT1 transcription and drive immune evasion in hepatocellular carcinoma","volume":"44","author":"Han","year":"2025","journal-title":"Oncogene"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217191","article-title":"RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma","volume":"604","author":"Han","year":"2024","journal-title":"Cancer Lett"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2023.2254884","article-title":"Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction","volume":"23","author":"Li","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"key":"B53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41419-023-05919-5","article-title":"Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity","volume":"14","author":"Yan","year":"2023","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1856643\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:46:57Z","timestamp":1787118417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1856643\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2026.1856643"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1856643","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1856643"}}